(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GS EFFEX

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GS EFFEX

ST13

US500000079384105

Class

1, 5, 40, 42

Filing

79384105

Registration

7452422

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

05/18/2025

Trademark type

Word

Nice classes

1, 5, 40, 42

Filing date

09/21/2023

Registration date

07/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/23/2024

Last transaction

05/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

BRADLEY, EVELYN

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Lonza Ltd.

Representatives

LAWRENCE J CRAIN GREER BURNS & CRAIN LTD

Technical classification

Nice Classes

Class 1Class 5Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations for scientific researchpharmaceutical researchclinical research and for industrial purposes namelygenetically modified cells and vectors for production of humananimal and synthetic proteins

Class 5

Biological preparationsgenetically modified cells and genetically modified vectors for production of humananimal and synthetic proteinsfor medical and clinical use in human and animal therapies

Class 40

Custom manufacturing according to third-party orders and specifications of genetically modified cells and vectors for production of humananimal and synthetic proteinsfor clinical and commercial use in scientific research and in pharmaceutical researchas well as for clinical and commercial use in human and animal therapies

Class 42

Medical and scientific research in the field of biotechnology; technical consultancy and project planning in the field of biological research relating to proteins; scientific research and development in the field of protein research for others

Publications

History of USPTO decisions and trademark events.

32 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/17/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/29/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/29/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/08/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/16/2025

FIMP

FINAL DISPOSITION PROCESSED

01/16/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/24/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/12/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/23/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/07/2024

PUBO

PUBLISHED FOR OPPOSITION

05/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/17/2024

RFNT

REFUSAL PROCESSED BY IB

04/08/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/30/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

03/30/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/30/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

03/30/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/30/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/29/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/28/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/28/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/20/2024

RFRR

REFUSAL PROCESSED BY MPU

03/20/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/29/2024

CNRT

NON-FINAL ACTION WRITTEN

02/28/2024

DOCK

ASSIGNED TO EXAMINER

02/23/2024

MAFR

APPLICATION FILING RECEIPT MAILED

12/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/04/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/30/2023

Continuous trademark protection

Get notified about every new filing that threatens GS EFFEX or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.